BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 30, Issue 19
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4991)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-2) series.
Item 
Count 
PDF107
HTML3930
Tables (1-2)364
 Sum=4401
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse106
Download275
 Sum=381
May 21, 2024 (publication date) through Jul 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Ninomiya Y, Yamamoto M, Kazuno A, Nabeshima K, Nishi T, Mori M. Immunotherapy for esophageal cancer: Where are we now and where can we go. World J Gastroenterol 2024; 30(19): 2496-2501 [PMID: 38817664 DOI: 10.3748/wjg.v30.i19.2496]
URL: https://www.wjgnet.com/1948-5204/full/v30/i19/2496.htm
Number Citing Articles
1
Hong-Wei Gao, Kai-Fu Chang, Xiao-Fan Huang, Peng-Yun Hung, Ming-Chang Hsieh, Nu-Man Tsai. Juniperus indica Bertol Extract Combined with 5-Fluorouracil Synergistically Suppresses the Growth of Esophageal Squamous Cell Carcinoma Cells. Natural Product Communications 2025; 20(2) doi: 10.1177/1934578X251324602
2
Atsuto Katano. Palliative external beam radiotherapy for dysphagia management in advanced esophageal cancer: a narrative perspective. Oncologie 2025; 27(3): 439 doi: 10.1515/oncologie-2025-0087
3
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
4
Sung Eun Kim, Kyoungwon Jung, Moo In Park. Immunotherapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma. Journal of Digestive Cancer Research 2024; 12(2): 72 doi: 10.52927/jdcr.2024.12.2.72
5
Qin Wang, Qing-Rong Li, Lei Xu, Zi-Chun Yuan, Xiao Liu, Mao-Ju Tang, Man Luo, Xiao-Wu Zhong, Qiang Ma, Xiao-Lan Guo. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World Journal of Gastrointestinal Oncology 2025; 17(1): 99376 doi: 10.4251/wjgo.v17.i1.99376
6
Seungbyn Baek, Junha Cha, Min Hee Hong, Gamin Kim, Yoon Woo Koh, Dahee Kim, Wonrak Son, Chan‐Young Ock, Seungeun Lee, Martin Hemberg, Seong Yong Park, Hye Ryun Kim, Insuk Lee. Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses. Cancer Communications 2025;  doi: 10.1002/cac2.70046
7
Grigorios Christodoulidis, Sara Eirini Agko, Konstantinos Eleftherios Koumarelas, Marina Nektaria Kouliou, Dimitris Zacharoulis. Advancements and challenges in the treatment of esophageal cancer: A comprehensive review. World Journal of Clinical Oncology 2024; 15(12): 1463-1467 doi: 10.5306/wjco.v15.i12.1463
8
Yoshiaki Shoji, Kohei Kanamori, Kazuo Koyanagi, Tetsuya Otsuka, Rie Nakashima, Kohei Tajima, Mika Ogimi, Yamato Ninomiya, Miho Yamamoto, Akihito Kazuno, Takayuki Nishi, Masaki Mori. Conversion surgery for esophageal and esophagogastric junction cancer. International Journal of Clinical Oncology 2024; 29(12): 1777 doi: 10.1007/s10147-024-02639-4
9
Shilong Wu, Chenyang Xu, Huafeng Liu. Case report: Toxic epidermal necrolysis induced by tislelizumab in a patient with esophageal squamous cell carcinoma. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1522525
10
Zijian Qiu, Mixue Sun, Chunyan Dai, Xiaoping Zhu. Immunotherapy-associated autoimmune hemolytic anemia induced by anti-PD-1 therapy in esophageal cancer: A case report and literature review. Medicine 2025; 104(15): e42174 doi: 10.1097/MD.0000000000042174
11
Xihao Xie, Hai Zhang, Haiquan He, Bomeng Wu, Ying Chen, Wanli Lin, Qingyi Feng, Qunqing Chen. Postoperative adjuvant immunotherapy for pathological stage II–IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1517001
12
Yingjie Sun, Yuheng Tang, Qi Qi, Jianyu Pang, Yongzhi Chen, Hui Wang, Jiaxiang Liang, Wenru Tang. 101 Machine Learning Algorithms for Mining Esophageal Squamous Cell Carcinoma Neoantigen Prognostic Models in Single-Cell Data. International Journal of Molecular Sciences 2025; 26(7): 3373 doi: 10.3390/ijms26073373
13
Hossein Taghizadeh, Harun Fajkovic. Immunotherapy in the Management of Penile Cancer—A Systematic Review. Cancers 2025; 17(5): 883 doi: 10.3390/cancers17050883
14
Jian-Zhou Tian, Li Zhang, Fu-Yong Lin, Ren-Jiao He, Wen-Rong Tian, Liu Yan, Guo-Xin Huang, Jin-Wei Ai, Bin Pei, De-Sheng Li. The efficacy and safety of PD-1 inhibitors combined with chemotherapy treatment for advanced esophageal cancer: a network meta-analysis. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1515263
15
Wei Wei, Xiao-Lei Zhang, Hong-Zhen Wang, Lin-Lin Wang, Jing-Li Wen, Xin Han, Qian Liu. Application of deep learning models in the pathological classification and staging of esophageal cancer: A focus on Wave-Vision Transformer. World Journal of Gastroenterology 2025; 31(19): 104897 doi: 10.3748/wjg.v31.i19.104897
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345